Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of hard corns. It provides relief from pain associated with corns through its effective removal properties.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The affected area should be washed and dried thoroughly prior to application. If necessary, the medicated patch may be cut to fit the size of the corn. The adhesive side of the medicated patch should be applied directly onto the corn. Following application, the medicated patch must be covered with a pad to ensure proper adherence.

The medicated patch should remain in place for 48 hours. After this period, the patch must be removed. This procedure may be repeated every 48 hours as needed, for a maximum duration of 14 days, or until the corn is completely removed. To facilitate the removal of the corn, it is recommended to soak the corn in warm water for 15 minutes prior to patch application.

Contraindications

Use is contraindicated in patients with diabetes due to the potential for adverse effects on glycemic control. Additionally, the product should not be applied to individuals with poor blood circulation, as this may exacerbate underlying conditions. Application is also contraindicated on irritated skin or any area that is infected or reddened, as this could lead to further irritation or complications.

Warnings and Precautions

For external use only. This product is contraindicated in individuals with diabetes, as it may exacerbate existing conditions. Additionally, it should not be applied to patients with poor blood circulation, as this may lead to further complications.

Application of this product is not recommended on irritated skin or any area that is infected or reddened. Healthcare professionals should advise patients to discontinue use and seek medical attention from a doctor or podiatrist if discomfort persists after application.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients should be aware that the product is intended for external use only. It is contraindicated for individuals with diabetes or those who have poor blood circulation. Additionally, the product should not be applied to irritated skin or any area that is infected or reddened.

In the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. Furthermore, the product should be kept out of reach of children to prevent any potential harm.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (medicated corn removers). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is currently no information available regarding the use of Salicylic Acid medicated corn removers patch during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering the use of this product in pregnant patients. Healthcare professionals are advised to exercise caution and consider the potential risks versus benefits when recommending this treatment to women of childbearing potential. Further studies may be necessary to fully understand the implications of Salicylic Acid use during pregnancy.

Lactation

There is no information available regarding the use of Salicylic Acid Medicated Corn Removers Patch in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider this lack of data when advising lactating patients.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms may vary depending on the specific substance involved, and monitoring for any adverse effects is essential.

Management of overdosage should include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately. This action is essential to ensure the patient's safety and well-being.

Additionally, patients should be informed that if they experience persistent discomfort, they should consult their doctor or podiatrist for further evaluation and management. This guidance will help ensure that any underlying issues are addressed appropriately.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It is essential to store the product at a temperature range of 15°C to 30°C (59°F to 86°F) to maintain its efficacy and stability. Proper container requirements should be adhered to, ensuring that the product is kept in a suitable environment. Special handling needs should be observed to prevent exposure to extreme temperatures or conditions that may compromise the integrity of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)